Truvestments Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.9K Buy
98
+10
+11% +$3.71K 0.01% 588
2026
Q1
$25.8K Hold
88
﹤0.01% 593
2025
Q4
$30.8K Hold
88
0.01% 520
2025
Q3
$28.4K Sell
88
-80
-48% -$24.9K 0.01% 529
2025
Q2
$65.4K Hold
168
0.01% 353
2025
Q1
$73K Sell
168
-10
-6% -$4.01K 0.02% 333
2024
Q4
$65.5K Buy
178
+6
+3% +$2.51K 0.02% 335
2024
Q3
$89.5K Buy
+172
New +$91.9K 0.02% 286
2024
Q2
Sell
-417
Closed -$216K 375
2024
Q1
$216K Sell
417
-121
-22% -$60.2K 0.08% 207
2023
Q4
$253K Sell
538
-77
-13% -$35.6K 0.11% 188
2023
Q3
$268K Sell
615
-3
-0.5% -$1.36K 0.14% 144
2023
Q2
$275K Sell
618
-30
-5% -$13.8K 0.14% 137
2023
Q1
$298K Sell
648
-560
-46% -$267K 0.16% 114
2022
Q4
$620K Sell
1,208
-2,892
-71% -$1.47M 0.35% 68
2022
Q3
$1.86M Sell
4,100
-31
-0.8% -$14.8K 1.17% 28
2022
Q2
$1.99M Sell
4,131
-282
-6% -$140K 1.17% 25
2022
Q1
$2.17M Sell
4,413
-258
-6% -$118K 1.19% 30
2021
Q4
$2.17M Sell
4,671
-40
-0.8% -$16.8K 1.09% 26
2021
Q3
$1.76M Buy
4,711
+291
+7% +$111K 0.97% 42
2021
Q2
$1.69M Buy
4,420
+862
+24% +$329K 0.93% 44
2021
Q1
$1.28M Buy
3,558
+550
+18% +$177K 0.72% 49
2020
Q4
$965K Buy
3,008
+122
+4% +$37.4K 0.67% 51
2020
Q3
$775K Buy
2,886
+2,685
+1,336% +$722K 0.7% 48
2020
Q2
$52K Buy
+201
New +$53.6K 0.05% 201

Other funds holding ELV

Truvestments Capital's ELV Position: Q2 2026 in Review

Truvestments Capital increased its Elevance Health (ELV) stake by 11% in Q2 2026, buying an estimated $3.71K and bringing the position to 98 shares worth $37.9K. The position accounts for 0.01% of the portfolio, ranked #588.

Truvestments Capital first reported a position in ELV in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.17M in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Truvestments Capital held 98 shares of Elevance Health worth $37.9K as of Q2 2026.
  • Truvestments Capital bought 10 Elevance Health shares in Q2 2026, an estimated $3.71K.
  • Elevance Health made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #588 holding.
  • Truvestments Capital first reported a position in Elevance Health in Q2 2020 and has held it in 24 quarters since.
  • Truvestments Capital's Elevance Health position peaked at $2.17M in Q1 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.